Meningococcal disease

Andrew Meigs (18) receives Bexsero®, the Novartis meningococcal group B vaccine, which was recently approved by the FDA for those ages 10-25. Bexsero helps protect against group B, one of the most prevalent types of meningococcal disease in the US, in two doses. Andrews sister Leslie (also pictured) is a survivor who advocates for vaccination in Texas, their home state. Despite appropriate treatment, as many as 10 percent of people with meningococcal disease will die and almost one in five survivors will suffer long-term disability. Bexsero is not expected to cover all group B strains.

Leon County confirms three cases of meningitis-causing disease

Valerie Crowder

A potentially deadly disease that can cause meningitis is now in Tallahassee after health officials warned of a statewide outbreak last month.

Health News Florida

Orange County health care providers order more meningitis vaccine amid outbreak

Danielle Prieur

Six men in the county have been diagnosed with meningitis this year, and three men in their 30s have died from the illness. It's the most cases the area has seen in five years.

Health News Florida

Meningococcal warnings issued after Florida outbreak

Health News Florida

The state Department of Health advised vaccinations for college students, gay men, people with HIV and immunocompromised individuals.